ESR1 and endocrine therapy resistance: more than just mutations

Ann Oncol. 2018 Apr 1;29(4):787-789. doi: 10.1093/annonc/mdy081.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Breast
  • Breast Neoplasms*
  • Estrogen Receptor alpha / genetics
  • Humans
  • Mutation
  • Tamoxifen

Substances

  • Estrogen Receptor alpha
  • Tamoxifen